Hips using Palacos Antibiotic Cement - Heraeus
-
Upload
khangminh22 -
Category
Documents
-
view
3 -
download
0
Transcript of Hips using Palacos Antibiotic Cement - Heraeus
2
3
4
12
17
Appendix A lists details of all Palacos Antibiotic Cement products included in this report.
This report has been produced by the National Joint Registry of England, Wales and Northern Ireland (NJR). It
summarises usage and outcomes associated with the Hips using Palacos Antibiotic Cement up to the specified
dates. This analysis is based on data collected by the NJR and PROMs data collected by NHS Digital for the
following combinations of products:
This report is made available to Heraeus Medical under licence. Under this licence, Heraeus Medical is free to
distribute this document, subject to the restrictions specified in the National Joint Registry Supplier Feedback
Data Access and Use Code of Practice.
Cemented Components
Hips using Palacos Antibiotic Cement
APPENDIX A – Component List
Produced on:
Licensed for use until:
18 May 2021
18 May 2022
ContentsRecorded Usage in NJR
Patient and Procedure Details
Revision and Survivorship
Patient Reported Outcome Measures
Implant Summary Report for: Heraeus Medical
Hips using Palacos Antibiotic Cement
NJR Database extract:
Comprising PRIMARY hips implanted up to: 07 March 2021
06 May 2021
Page 1Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Summary Report for:
Implant Usage
Date of first recorded usage in the NJR:
Date of last recorded usage in this dataset:
Maximum implantation time: 15.5 years
Mean implantation time: 5.4 years
Current
Outcome
Pre-
20102010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Total %
Death 24358 6641 6637 6556 6145 5582 4757 3892 2897 1982 1180 272 9 70908 17.2%
Revised 2185 508 517 566 553 573 607 574 521 432 364 143 8 7551 1.8%
Unrevised 30480 12275 15135 18728 22523 26503 29640 33763 36153 38848 42038 23990 3508 333584 81.0%
Total 57023 19424 22289 25850 29221 32658 35004 38229 39571 41262 43582 24405 3525 412043 100%
06 September 2005
07 March 2021
Totals Recorded in NJR
Procedures
Hips using Palacos Antibiotic Cement
NJR Recorded Usage
Year of implantation
Cumulative Total
412,043
434
2,950
5,070
Consultants
Implanting Surgeons
Centres
Patients 367,751
0
50000
100000
150000
200000
250000
300000
350000
400000
450000
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
20
17
20
18
20
19
20
20
20
21
20
22
Cumulative Procedures
Procedures
0
1000
2000
3000
4000
5000
6000
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
20
17
20
18
20
19
20
20
20
21
20
22
Cumulative Surgeons and Centres
Centres Consultants Implanting Surgeons
Page 2Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Summary Report for:
Patient Details
Hips using Palacos
Antibiotic Cement
All other cement
brands in NJR
All NJR hip
replacement
Total Procedures 412,043 324,344 1,285,207
Total Patients 367,751 290,394 1,082,079
Demographics
Mean age 71.6 70.2 68.6
< 50 3.1% 5.0% 5.9%
50 – 59 8.8% 11.3% 13.8%
60 – 69 24.8% 25.2% 28.9%
70 – 79 40.6% 37.7% 34.7%
≥ 80 22.7% 20.7% 16.6%
Median BMI 28 28 28
% BMI information available 70.3% 57.4% 62.7%
Underweight ( BMI < 18.5) 1.0% 1.1% 0.9%
Normal (18.5 ≤ BMI < 25) 21.5% 22.4% 20.8%
Overweight (25 ≤ BMI < 30) 39.7% 40.2% 39.6%
Obese I (30 ≤ BMI < 35) 25.4% 24.6% 25.8%
Obese II (35 ≤ BMI < 40) 9.3% 8.8% 9.7%
Obese III (BMI ≥ 40) 3.1% 2.9% 3.3%
% Male 35.8% 38.6% 40.2%
ASA Grades
P1 - Fit and healthy 10.8% 15.9% 15.6%
P2 - Mild disease not incapacitating 68.9% 65.1% 67.7%
P3 - Incapacitating systemic disease 19.6% 18.3% 16.2%
P4 / P5 0.7% 0.7% 0.6%
Indications
Osteoarthritis 89.91% 90.06% 91.26%
Rheumatoid Arthritis 1.42% 1.41% 1.32%
Avascular Necrosis 2.47% 2.46% 2.53%
Fractured Neck of Femur 5.36% 4.62% 3.69%
CDH/DDH 1.08% 1.33% 1.58%
Other 2.14% 2.54% 2.12%
Total of indications may exceed total number of implants, since more than one indication can be listed per
case.
Hips using Palacos Antibiotic Cement
Patient / Procedure Details
Page 3Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Summary Report for:
Reasons for Revision - all bearing types
Reasons for revision of primary procedures in which the implant was used.
Reason for Revision Revised†
Expected Revisions* p value
Unexplained Pain 554 644.04 <0.001
Dislocation / Subluxation 1887 1874.52 0.689
Adverse Soft Tissue Reaction 342 447.56 <0.001
Infection 1657 1681.64 0.388
Aseptic Loosening - Stem 570 662.84 <0.001
Aseptic Loosening - Socket 1053 1082.01 0.273
Periprosthetic Fracture Stem 1455 1505.57 0.065
Periprosthetic Fracture Socket 134 141.19 0.403
Malalignment Stem 174 186.87 0.206
Malalignment Socket 371 345.27 0.063
Wear Of Acetabular Component 258 239.83 0.149
Lysis Stem 153 171.39 0.099
Lysis Socket 227 226.47 0.968
Implant Fracture Stem 126 127.73 0.865
Implant Fracture Socket 33 34.19 0.818
Implant Fracture Head 33 36.74 0.449
Dissociation of Liner 90 79.15 0.092
Other / reason not recorded 284 311.64 0.044
Total Revised 7551 7885.00 <0.001
† multiple reasons may be listed for one revision procedure
Significantly better, p < 0.001
Significantly better, p < 0.05
Significantly worse p < 0.05
Significantly worse p < 0.001
Components RevisedNumber of
procedures
Hips using Palacos
Antibiotic Cement
All other cement
brands in NJR
Femoral only 1789 24% 18%
Acetabular only 1628 22% 17%
Both femoral and acetabular 3244 43% 60%
Neither femoral nor acetabular
revision recorded *890 12% 5%
* includes isolated head and/or liner exchange
Hips using Palacos Antibiotic Cement
Revision and Survivorship
* Based on All NJR Hips with Cement, adjusted for agegroup,
gender, indications, and implantation year
Page 4Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Summary Report for:
Reasons for Revision - excluding Metal on Metal
Reasons for revision of non-MoM primary procedures in which the implant was used.
Reason for Revision Revised†
Expected
Revisions* p value
Unexplained Pain 423 419.98 0.844
Dislocation / Subluxation 1868 1880.41 0.684
Adverse Soft Tissue Reaction 112 101.78 0.175
Infection 1628 1679.08 0.063
Aseptic Loosening - Stem 509 597.33 <0.001
Aseptic Loosening - Socket 1007 1039.21 0.194
Periprosthetic Fracture Stem 1393 1412.68 0.442
Periprosthetic Fracture Socket 133 136.33 0.703
Malalignment Stem 167 175.25 0.374
Malalignment Socket 344 317.41 0.033
Wear Of Acetabular Component 250 235.80 0.245
Lysis Stem 121 132.53 0.235
Lysis Socket 192 186.97 0.642
Implant Fracture Stem 117 123.63 0.432
Implant Fracture Socket 33 33.13 1
Implant Fracture Head 29 32.56 0.367
Dissociation of Liner 90 76.64 0.028
Other / reason not recorded 232 227.83 0.697
Total Revised 6989 7145.03 0.008
† multiple reasons may be listed for one revision procedure
Significantly better, p < 0.001
Significantly better, p < 0.05
Significantly worse p < 0.05
Significantly worse p < 0.001
Components RevisedNumber of
procedures
Hips using
Palacos Antibiotic
Cement
All other cement brands in
NJR
Femoral only 1740 25% 22%
Acetabular only 1575 23% 23%
Both femoral and acetabular 2792 40% 48%
Neither femoral nor acetabular
revision recorded *882 13% 7%
* includes isolated head and/or liner exchange
Hips using Palacos Antibiotic Cement
Revision and Survivorship
* Based on All NJR Hips with Cement (excluding metal on
metal), adjusted for agegroup, gender, indications, and
implantation year
Page 5Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Summary Report for:
Cumulative Revision Rate
AdjustmentHazard Ratio
(95% CI)p- value
0.78 ‡
(0.76 - 0.80)
0.91
(0.88 - 0.94)
‡ Hazard ratio varies with time
All bearings. Adjusted for age, gender,
year cohort and indications.<0.001
Endpoint: All reasons for revision. All Bearing types
Hips using Palacos Antibiotic Cement
Revision and Survivorship
Cox Proportional Hazards model for revision risk ratio of Hips using Palacos Antibiotic Cement / All
other cement brands in NJR, with endpoint as any revision.
All bearings. Unadjusted. <0.001 ‡
0.0%
1.0%
2.0%
3.0%
4.0%
5.0%
6.0%
7.0%
8.0%
0 2 4 6 8 10 12 14 16
Cu
mu
lati
ve R
evis
ion
Rat
e
Implantation time / years
All other cement brands in NJR
All other cement brands in NJR (adjusted)
Hips using Palacos Antibiotic Cement
Page 6Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Summary Report for:
Cumulative Revision Rate
AdjustmentHazard Ratio
(95% CI)p- value
0.93 ‡
(0.90 - 0.96)
0.95
(0.91 - 0.98)
‡ Hazard ratio varies with time
Excluding MoM. Adjusted for age,
gender, year cohort and indications.0.004
Hips using Palacos Antibiotic Cement
Revision and Survivorship
Endpoint: All reasons for revision. Excluding Metal-on-Metal
Cox Proportional Hazards model for revision risk ratio of Hips using Palacos Antibiotic Cement / All
other cement brands in NJR, with endpoint as any revision.
Excluding MoM, Unadjusted. <0.001 ‡
0.0%
1.0%
2.0%
3.0%
4.0%
5.0%
6.0%
7.0%
0 2 4 6 8 10 12 14 16
Cu
mu
lati
ve R
evis
ion
Rat
e
Implantation time / years
All other cement brands in NJR
All other cement brands in NJR (adjusted)
Hips using Palacos Antibiotic Cement
Page 7Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Summary Report for:
Cumulative Revision Rate
AdjustmentHazard Ratio
(95% CI)p- value
0.71 ‡
(0.68 - 0.73)
0.85
(0.82 - 0.89)
‡ Hazard ratio varies with time
All bearings. Adjusted for age, gender,
year cohort and indications.<0.001
Hips using Palacos Antibiotic Cement
Revision and Survivorship
Endpoint: Cemented Component Revision. All Bearing types
Cox Proportional Hazards model for revision risk ratio of Hips using Palacos Antibiotic Cement / All
other cement brands in NJR, with endpoint as any revision.
All bearings. Unadjusted. <0.001 ‡
0.0%
1.0%
2.0%
3.0%
4.0%
5.0%
6.0%
7.0%
8.0%
0 2 4 6 8 10 12 14 16
Cu
mu
lati
ve R
evis
ion
Rat
e
Implantation time / years
All other cement brands in NJR
All other cement brands in NJR (adjusted)
Hips using Palacos Antibiotic Cement
Page 8Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Summary Report for:
Cumulative Revision Rate
AdjustmentHazard Ratio
(95% CI)p- value
0.87 ‡
(0.84 - 0.91)
0.91
(0.87 - 0.95)
‡ Hazard ratio varies with time
Excluding MoM. Adjusted for age,
gender, year cohort and indications.<0.001
Hips using Palacos Antibiotic Cement
Revision and Survivorship
Endpoint: Cemented Component Revision. Excluding Metal-on-Metal
Cox Proportional Hazards model for revision risk ratio of Hips using Palacos Antibiotic Cement / All
other cement brands in NJR, with endpoint as any revision.
Excluding MoM. Unadjusted. <0.001 ‡
0.0%
1.0%
2.0%
3.0%
4.0%
5.0%
6.0%
0 2 4 6 8 10 12 14 16
Cu
mu
lati
ve R
evis
ion
Rat
e
Implantation time / years
All other cement brands in NJR
All other cement brands in NJR (adjusted)
Hips using Palacos Antibiotic Cement
Page 9Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Summary Report for:
Endpoint: All revisions
Period
/yearsAt Risk
Hips using Palacos
Antibiotic Cement
All other cement
brands in NJRAll THR At Risk
Hips using Palacos
Antibiotic Cement
All other cement
brands in NJRAll THR
0 412,043 - - - 407,178 - - -
1 382,669 0.7% (0.7% - 0.7%) 0.7% (0.6% - 0.7%) 0.8% (0.8% - 0.8%) 377,920 0.7% (0.7% - 0.7%) 0.6% (0.6% - 0.7%) 0.8% (0.8% - 0.8%)
2 332,652 1.0% (0.9% - 1.0%) 1.0% (1.0% - 1.0%) 1.1% (1.1% - 1.2%) 328,061 1.0% (0.9% - 1.0%) 0.9% (0.9% - 1.0%) 1.1% (1.1% - 1.1%)
3 284,508 1.2% (1.2% - 1.3%) 1.3% (1.3% - 1.4%) 1.5% (1.4% - 1.5%) 280,059 1.2% (1.2% - 1.2%) 1.2% (1.1% - 1.2%) 1.3% (1.3% - 1.4%)
4 240,296 1.4% (1.4% - 1.5%) 1.6% (1.6% - 1.7%) 1.8% (1.7% - 1.8%) 236,006 1.4% (1.4% - 1.4%) 1.4% (1.3% - 1.4%) 1.6% (1.5% - 1.6%)
5 198,266 1.7% (1.6% - 1.7%) 2.0% (1.9% - 2.1%) 2.1% (2.1% - 2.1%) 194,151 1.6% (1.5% - 1.6%) 1.6% (1.6% - 1.7%) 1.8% (1.8% - 1.8%)
6 160,433 1.9% (1.8% - 1.9%) 2.4% (2.3% - 2.4%) 2.5% (2.5% - 2.5%) 156,494 1.8% (1.7% - 1.8%) 1.9% (1.8% - 1.9%) 2.0% (2.0% - 2.0%)
7 126,918 2.1% (2.1% - 2.2%) 2.8% (2.7% - 2.8%) 2.9% (2.8% - 2.9%) 123,162 2.0% (1.9% - 2.0%) 2.1% (2.1% - 2.2%) 2.3% (2.2% - 2.3%)
8 97,805 2.4% (2.3% - 2.4%) 3.2% (3.1% - 3.2%) 3.3% (3.3% - 3.3%) 94,215 2.2% (2.1% - 2.3%) 2.4% (2.3% - 2.5%) 2.5% (2.5% - 2.6%)
9 73,529 2.7% (2.6% - 2.7%) 3.6% (3.5% - 3.7%) 3.7% (3.7% - 3.8%) 70,133 2.5% (2.4% - 2.5%) 2.7% (2.6% - 2.8%) 2.8% (2.8% - 2.9%)
10 53,292 3.0% (2.9% - 3.0%) 4.0% (4.0% - 4.1%) 4.2% (4.1% - 4.2%) 50,250 2.7% (2.7% - 2.8%) 3.1% (3.0% - 3.1%) 3.1% (3.1% - 3.2%)
11 37,292 3.3% (3.2% - 3.4%) 4.5% (4.4% - 4.6%) 4.7% (4.6% - 4.7%) 34,653 3.1% (3.0% - 3.2%) 3.5% (3.4% - 3.6%) 3.5% (3.4% - 3.5%)
12 24,252 3.8% (3.6% - 3.9%) 5.1% (5.0% - 5.2%) 5.2% (5.2% - 5.3%) 22,203 3.5% (3.3% - 3.6%) 4.0% (3.9% - 4.1%) 3.9% (3.9% - 4.0%)
13 13,306 4.1% (3.9% - 4.2%) 5.6% (5.5% - 5.7%) 5.7% (5.7% - 5.8%) 12,133 3.7% (3.6% - 3.9%) 4.4% (4.3% - 4.5%) 4.3% (4.3% - 4.4%)
14 5,013 4.4% (4.2% - 4.6%) 6.1% (6.0% - 6.2%) 6.2% (6.1% - 6.3%) 4,650 4.0% (3.8% - 4.2%) 4.8% (4.7% - 5.0%) 4.7% (4.7% - 4.8%)
15 ( - ) 6.6% (6.5% - 6.8%) 6.7% (6.6% - 6.8%) ( - ) 5.4% (5.2% - 5.5%) 5.2% (5.1% - 5.3%)
Cumulative revision rate with 95% confidence intervals Rate is only reported for times where more than 40 remain at risk
Excluding Metal on Metal BearingsAll Bearing types
Revision and Survivorship
Cumulative Revision Rate
Hips using Palacos Antibiotic Cement
Page 10Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Summary Report for:
Endpoint: Cemented Component Revision
Period
/yearsAt Risk
Hips using Palacos
Antibiotic Cement
All other cement
brands in NJRAll THR At Risk
Hips using Palacos
Antibiotic Cement
All other cement
brands in NJRAll THR
0 412,043 - - - 407,178 - - -
1 382,669 0.5% (0.4% - 0.5%) 0.5% (0.5% - 0.5%) ( - ) 377,920 0.5% (0.4% - 0.5%) 0.4% (0.4% - 0.5%) ( - )
2 332,652 0.7% (0.7% - 0.7%) 0.8% (0.8% - 0.8%) ( - ) 328,061 0.7% (0.6% - 0.7%) 0.7% (0.7% - 0.7%) ( - )
3 284,508 0.9% (0.9% - 0.9%) 1.1% (1.0% - 1.1%) ( - ) 280,059 0.9% (0.8% - 0.9%) 0.9% (0.9% - 0.9%) ( - )
4 240,296 1.1% (1.0% - 1.1%) 1.3% (1.3% - 1.4%) ( - ) 236,006 1.0% (1.0% - 1.1%) 1.1% (1.0% - 1.1%) ( - )
5 198,266 1.3% (1.2% - 1.3%) 1.7% (1.6% - 1.7%) ( - ) 194,151 1.2% (1.2% - 1.2%) 1.3% (1.3% - 1.3%) ( - )
6 160,433 1.5% (1.4% - 1.5%) 2.0% (2.0% - 2.1%) ( - ) 156,494 1.4% (1.3% - 1.4%) 1.5% (1.5% - 1.6%) ( - )
7 126,918 1.6% (1.6% - 1.7%) 2.4% (2.3% - 2.4%) ( - ) 123,162 1.5% (1.5% - 1.6%) 1.7% (1.7% - 1.8%) ( - )
8 97,805 1.9% (1.8% - 1.9%) 2.7% (2.7% - 2.8%) ( - ) 94,215 1.7% (1.7% - 1.8%) 2.0% (1.9% - 2.0%) ( - )
9 73,529 2.1% (2.0% - 2.2%) 3.1% (3.1% - 3.2%) ( - ) 70,133 1.9% (1.9% - 2.0%) 2.3% (2.2% - 2.3%) ( - )
10 53,292 2.4% (2.3% - 2.5%) 3.6% (3.5% - 3.7%) ( - ) 50,250 2.2% (2.1% - 2.3%) 2.6% (2.5% - 2.7%) ( - )
11 37,292 2.7% (2.6% - 2.8%) 4.0% (3.9% - 4.1%) ( - ) 34,653 2.5% (2.4% - 2.6%) 3.0% (2.9% - 3.1%) ( - )
12 24,252 3.1% (3.0% - 3.2%) 4.6% (4.5% - 4.7%) ( - ) 22,203 2.8% (2.7% - 2.9%) 3.4% (3.3% - 3.5%) ( - )
13 13,306 3.4% (3.2% - 3.5%) 5.0% (4.9% - 5.1%) ( - ) 12,133 3.0% (2.9% - 3.2%) 3.8% (3.7% - 3.9%) ( - )
14 5,013 3.6% (3.4% - 3.8%) 5.5% (5.3% - 5.6%) ( - ) 4,650 3.3% (3.1% - 3.5%) 4.2% (4.1% - 4.4%) ( - )
15 ( - ) 6.0% (5.8% - 6.1%) ( - ) ( - ) 4.7% (4.5% - 4.9%) ( - )
Cumulative revision rate with 95% confidence intervals Rate is only reported for times where more than 40 remain at risk
Revision and Survivorship
Cumulative Revision Rate
All Bearing types Excluding Metal on Metal Bearings
Hips using Palacos Antibiotic Cement
Page 11Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Summary Report for:
Comprising PROMs data up to and including: 31/12/2019
Hips using Palacos Antibiotic Cement
Patient Reported Outcomes
PROMs Analysis
0
6
12
18
24
30
36
42
48
Mean Pre-op Mean 6 months post-op
Oxf
ord
Sco
re (
un
adju
sted
)
Hips using Palacos Antibiotic Cement
All other cement brands in NJR
-0.6
-0.4
-0.2
0
0.2
0.4
0.6
0.8
1
Mean Pre-op Mean 6 months post-op
EQ5
D S
core
(u
nad
just
ed)
Hips using Palacos Antibiotic Cement
All other cement brands in NJR
Page 12Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Summary Report for:
PROMs Analysis Comprising PROMs data up to and including: 31/12/2019
Oxford Hip Score
(0 - 48)
Hips using Palacos
Antibiotic Cement
All other cement
brands in NJRAll THR in NJR
Paired Records 121,751 79,894 342,959
PreOp score 17.5 (17.5 - 17.6) 17.6 (17.5 - 17.6) 17.9 (17.9 - 18.0)
6 month score 39.2 (39.1 - 39.2) 38.9 (38.9 - 39.0) 39.5 (39.5 - 39.5)
6 month score (adjusted) 39.4 (39.4 - 39.5) 39.3 (39.3 - 39.4) 39.5 (39.5 - 39.5)
Health gain 21.6 (21.6 - 21.7) 21.3 (21.3 - 21.4) 21.6 (21.5 - 21.6)
Health gain (adjusted) 21.5 (21.5 - 21.6) 21.4 (21.3 - 21.5) 21.6 (21.5 - 21.6)
p value (adjusted health gain)
Score Improved 97.4% 97.2% 97.3%
EQ-5D Index
(-0.59 - 1.00)
Hips using Palacos
Antibiotic Cement
All other cement
brands in NJRAll THR in NJR
Paired Records 111,587 73,322 315,677
PreOp score 0.340 (0.338 - 0.342) 0.339 (0.337 - 0.341) 0.353 (0.352 - 0.354)
6 month score 0.788 (0.787 - 0.790) 0.782 (0.781 - 0.784) 0.794 (0.794 - 0.795)
6 month score (adjusted) 0.793 (0.791 - 0.794) 0.790 (0.789 - 0.792) 0.794 (0.794 - 0.795)
Health gain 0.448 (0.446 - 0.450) 0.443 (0.441 - 0.446) 0.441 (0.440 - 0.442)
Health gain (adjusted) 0.439 (0.438 - 0.441) 0.437 (0.436 - 0.439) 0.441 (0.441 - 0.442)
p value (adjusted health gain)
Score Improved 89.8% 89.5% 89.7%
EQ-VAS
(0 - 100)
Hips using Palacos
Antibiotic Cement
All other cement
brands in NJRAll THR in NJR
Paired Records 106,585 70,419 303,007
PreOp score 64.4 (64.3 - 64.6) 64.4 (64.2 - 64.5) 64.8 (64.7 - 64.9)
6 month score 76.5 (76.4 - 76.6) 76.0 (75.9 - 76.1) 77.0 (76.9 - 77.1)
6 month score (adjusted) 76.9 (76.8 - 77.0) 76.7 (76.6 - 76.8) 77.0 (76.9 - 77.0)
Health gain 12.1 (12.0 - 12.2) 11.6 (11.4 - 11.8) 12.2 (12.1 - 12.3)
Health gain (adjusted) 12.2 (12.1 - 12.3) 11.9 (11.8 - 12.0) 12.2 (12.1 - 12.3)
p value (adjusted health gain)
Score Improved 66.0% 65.1% 66.4%
Figures in parentheses represent the 95% confidence interval for the mean
Adjusted scores correspond to the NHS Digital version 3 casemix-adjustment model. This includes patient
variables from PROMs, HES, and IMD data.
Hips using Palacos Antibiotic Cement
Patient Reported Outcomes
0.018
0.26
0.006
Page 13Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Summary Report for:
Responses are not case mix adjusted
Chi Squared p-value for difference: 0.271
Answer to 6-months general health question: Overall, how are your
problems now, compared to before your operation?
Chi Squared p-value for difference: 0.442
Answer to 6-months general health question: How would you describe
the results of your operation?
Patient Reported Outcomes
Hips using Palacos Antibiotic Cement
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Hips using PalacosAntibiotic Cement
All other cementbrands in NJR
Success
Much worse
A little worse
About the same
A little better
Much better
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Hips using PalacosAntibiotic Cement
All other cementbrands in NJR
Satisfaction
Poor
Fair
Good
Very Good
Excellent
Page 14Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Summary Report for:
Success
ResponseHips using Palacos
Antibiotic Cement
All other cement
brands in NJR
Much better 107124 70021
A little better 10816 7227
About the same 2901 1998
A little worse 1660 1106
Much worse 1113 715
Satisfaction
ResponseHips using Palacos
Antibiotic Cement
All other cement
brands in NJR
Excellent 49747 32794
Very Good 43420 28180
Good 21338 13973
Fair 7022 4674
Poor 1912 1293
Answer to 6-months general health question:
"Overall, how are your problems now, compared to before your operation?"
Answer to 6-months general health question:
"How would you describe the results of your operation?"
Hips using Palacos Antibiotic Cement
Patient Reported Outcomes
Page 15Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Summary Report for:
Disclaimer
Disclaimer
The National Joint Registry (NJR) produces this report through its contractor, Northgate Public Services (UK)
Limited (NPS) using data collected, collated and provided by third parties. As a result, neither NJR or NPS takes
any responsibility for the accuracy, currency, reliability and correctness of any data used or referred to in this
report, and disclaims all warranties in relation to such data, in each case to the maximum extent permitted by
legislation.
To the maximum extent permitted by law, neither the NJR or NPS shall have any liability (including but not
limited to liability by reason of negligence) for any loss, damage, cost or expense incurred or arising by reason of
any person using or relying on the data within this report and whether caused by reason of any error, omission
or misrepresentation in the report or otherwise. This report is not to be taken as advice. Third parties using or
relying on the data in this report do so at their own risk and will be responsible for making their own
assessment and should verify all relevant representations, statements and information with their own
professional advisers.
Hips using Palacos Antibiotic Cement
Page 16Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited
Catalogue Number
Description
Number Implanted
66017569 Palacos R +G 2x40 g 357297
66017771 Palacos R +G 1x40 g 2753
66017772 Palacos R +G 1x60 g 5033
66017773 Palacos R +G 2x20 g 4457
66017776 Palacos R +G 2x10 g 6
66017783 Palamed G 1x20 g 1
66017787 Palacos LV +G 1x40 g 4448
66031993 PALACOS MV+G 1x40g 134
66031995 Palacos MV+G 2x40 g 1743
66031996 PALACOS MV+G 1x20g 2
66031998 Palacos MV+G 2x20 g 5
66032000 Palacos MV+G 1x60 g 1
66037894 PALACOS LV+G 1x20g 1
66044273 Palacos R+G Pro 55 cement 168
66044274 Palacos R+G Pro 75 cement 384
Multiple Found Multiple Found 35610
Page 17Ref: Summary.Report.HP_Cement_Palacos Antibiotic.20/05/2021.16:58
©2021 Northgate Public Services (UK) Limited